CanSino Biologics said at the Pakistan‑China Business and Investment Summit in Islamabad it has reached an intent to cooperate with Pakistan's AGP Limited on a 13‑valent pneumococcal conjugate vaccine (PCV13i). The parties will further explore develo

2026-07-21

CanSino Biologics said at the Pakistan‑China Business and Investment Summit in Islamabad it has reached an intent to cooperate with Pakistan's AGP Limited on a 13‑valent pneumococcal conjugate vaccine (PCV13i). The parties will further explore development and market opportunities for the product in Pakistan.